Specialty Pharma Journal Specialty, Precision & Technology
SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) — Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The two companies will work …
Tag Archives: Janssen Pharmaceuticals
October, 2017
April, 2017
-
10 April
Janssen and PeptiDream Enter $1.15 Billion Drug Discover Deal
TOKYO–(BUSINESS WIRE)–PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)(TOKYO: 4587) announced today that it has entered into a multi-target discovery and optimization collaboration with US-based Janssen Pharmaceuticals, Inc. (“Janssen”), one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ). Under the agreement, facilitated by Johnson & Johnson Innovation, …
July, 2015
-
8 July
Short and Sweet
A treatment timeline of 52 weeks to clear the hepatitis C virus from the body, thankfully, is a thing of the past. Today, treatment horizons continue to get shorter and shorter for hepatitis C infections, with 12 weeks currently being a very typical treatment time for most hepatitis C patients. …
May, 2015
-
19 May
Janssen and Achillion Enter $1.1 Billion Hepatitis C Deal
Janssen Pharmaceuticals, Inc. has agreed to pay up to $1.1 billion for the rights to Achillion Pharmaceuticals’ pipeline of hepatitis C virus (HCV) assets. The company announced that it has entered into an exclusive worldwide license and collaboration arrangement with Achillion Pharmaceuticals to develop and commercialize one or more of …